Honest people tell the truth, even when given a chance to lie, as shown in an fMRI brain study of truth telling and prevarication from Harvard behavioral scientists.
Honest people tell the truth, even when given a chance to lie, as shown in an fMRI brain study of truth telling and prevarication from Harvard behavioral scientists.
The group, led by Joshua Greene, an assistant professor of psychology at Harvard, assessed 35 subjects who attempted to predict random coin flip outcomes while undergoing fMRI. Rewarded for accuracy and punished for inaccuracy, the study design also allowed them to cheat. Researchers found honest individuals displayed little to no additional neural activity in control-related brain regions when telling the truth, but liars did. Prevailing theories behind lie detection, “will” and “grace,” hypothesize that honesty results either from an active resistance to temptation or from a lack of response to it. Study findings lean toward the latter, according to researchers (Proc Natl Acad Sci USA 2009).
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 3
August 2nd 2025In the last of a three-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, share additional insights on practical considerations and potential challenges in integrating abbreviated breast MRI into clinical practice, and offer their thoughts on future research directions.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 3
August 2nd 2025In the third of a three-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, discuss strategies for maintaining the integrity of time-out procedures and communication with remote MRI scanning.
Twenty Years of CT Colonography for Colorectal Cancer Screening: What the Research Reveals
August 2nd 2025Computed tomography colonography (CTC) demonstrated a 91.6 percent positive predictive value (PPV) for polyps > 6 mm, according to new research involving over 9,000 patients who underwent CTC for primary asymptomatic colorectal cancer screening.